Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment

Research output: Contribution to journal › Journal article › Research › peer-review

  • Carla M L van Herpen
  • Lassen, Ulrik Niels
  • Ingrid M E Desar
  • Kathryn H Brown
  • Marcelo Marotti
  • Maja J A de Jonge
Original languageEnglish
JournalAnti-Cancer Drugs
Volume24
Issue number2
Pages (from-to)204-11
Number of pages8
ISSN0959-4973
DOIs
Publication statusPublished - 2013

ID: 120078048